# Glaropharm Ag – FDA Inspection, Jun 15, 2018

Source: https://www.keypedia.com/records/fda_inspections/glaropharm-ag/2830e9fa-e332-4204-a292-1d8a08967fef
Source feed: FDA_Inspections

> FDA inspection 1058998 of Glaropharm Ag, June 15, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1058998
- Company Name: Glaropharm Ag
- Inspection Date: 2018-06-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1207105 - 2023-05-31](https://www.keypedia.com/records/fda_inspections/glaropharm-ag/4567f4cb-ff69-4522-845c-71eba3c7dcc5)

## Related Officers

- [Investigator](https://www.keypedia.com/people/sandra-a-boyd/c469103a-0917-407a-b9d1-98273358dfeb)

Company: https://www.keypedia.com/companies/glaropharm-ag/c7d66974-1066-4007-909d-51c27de7cc95

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c